年別の研究成果
年別の研究成果
検索結果
-
2022
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells
Hattori, Y., Futo, T., Uozaki, R., Ichikawa, D., Yamaguchi, T., Yamamoto, T., Matsushita, M. & Hirao, M., 2022 4月, In: International journal of hematology. 115, 4, p. 605-608 4 p.研究成果: Letter › 査読
1 被引用数 (Scopus) -
2014
Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma
Hattori, Y., Ikeda, Y., Suzuki, Y., Ichikawa, D. & Matsushita, M., 2014 6月, In: British Journal of Haematology. 165, 5, p. 728-731 4 p.研究成果: Letter › 査読
Open Access5 被引用数 (Scopus) -
Detection of leukemia associated antigen-specific cytotoxic T cells in a patient with Philadelphia chromosome-positive leukemia during treatment with dasatinib
Matsushita, M., Tonegawa, K., Mori, T., Kohashi, S., Kato, J., Matsuki, E., Okamoto, S. & Hattori, Y., 2014 3月, In: Leukemia and Lymphoma. 55, 3, p. 722-724 3 p.研究成果: Letter › 査読
1 被引用数 (Scopus) -
2013
A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor
Hattori, Y., Du, W., Yamada, T., Ichikawa, D., Matsunami, S. & Matsushita, M., 2013 5月, In: Blood cancer journal. 3, 5, e115.研究成果: Letter › 査読
7 被引用数 (Scopus) -
2006
Thalidomide for the treatment of leptomeningeal multiple myeloma
Hattori, Y., Yabe, M., Okamoto, S., Morita, K., Tanigawara, Y. & Ikeda, Y., 2006 4月, In: European Journal of Haematology. 76, 4, p. 358-359 2 p.研究成果: Letter › 査読
21 被引用数 (Scopus) -
2005
Pulmonary hypertension and thalidomide therapy in multiple myeloma [2]
Hattori, Y., Shimoda, M., Okamoto, S., Satoh, T., Kakimoto, T. & Ikeda, Y., 2005 3月, In: British Journal of Haematology. 128, 6, p. 885-887 3 p.研究成果: Letter › 査読
Open Access17 被引用数 (Scopus)